Facts about Novartis Egypt
| Official Name | Novartis Pharma S.A.E. |
| Date of Establishment | 1962 |
|
|
|
| Main Activity of Business |
Pharmaceutical products |
| Divisions |
Pharma, Consumer Health and Sandoz |
| Therapeutic areas |
Oncology, blood diseases, cardiovascular diseases, organ transplant, tissue, immunity, neuroscience, ophthalmology, high blood pressure, respiratory diseases, rheumatism and arthritis. |
| Top products |
Voltaren, Diovan, Foradil, Tegretol, Glivec, Zometa, Miacalcic, Femara, Noeral. New products launched in 2008 and 2009: Aclasta, Stalevo, Anuva, Cefdin, Zaditen, Exforge. |
| Factory production capacity |
75 million packages annually |
| Export markets |
Nigeria, Venezuela, Chile, Brazil, Switzerland and the Middle East |
| Number of employees |
1239 |
| Novartis global headquarters |
Basel, Switzerland |
| Novartis headquarters in Egypt |
El Sawah Street, 11511 Amiria, Cairo, Egypt |
| Novartis global website | |
Locations
Novartis operates in 140 countries around the world.
About Novartis
On March 7th, 1996 Sandoz and Ciba-Geigy, the two Swiss-based chemical/life sciences giants, became Novartis.
